What Happened?
San Diego, CA-based IconOVir-Bio Appointed Mark McCamish as President and Chief Executive Officer
About the Company
IconOVir Bio is a preclinical-stage biotechnology company pioneering the next generation of oncolytic virus therapy to improve the treatment of patients with cancer. Our proprietary oncolytic virus platform is based on technology developed by scientific founder Clodagh O`Shea, Ph.D., of the Salk Institute. It is designed to address key limitations of first- and second-generation oncolytic viruses.
About the Person
Mark McCamish is President and Chief Executive Officer at IconOVir Bio. Previously, Mark held various senior HR leadership roles in the industry.
Info Source
News
Short Profile